Daily happenings?., page-491

common chart for biotechs at this stage of their life cycle
many people are just not made for investing in this sector

don't know what to make out of the price actions combined with rather decent volume in recent days, but I like it and have been one of the buyers at 4c
sold some parcels earlier this year at 6c or so, but now I've bought back and some.
for sure I'm not expecting them suddenly jumping out with a fda approval or cash flow positive or large profits or delicious dividends, it's not what biotechs at this stage are about.
for near term I only expect that they can move to a ptx100 registration trial, even if not and they need to take a longer journey, no big deal and that's always the default
I'm happy with where they are and am in for the long term, will buy more if sp dips below 4.5c again, cheers